S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

QNCX Quince Therapeutics Inc

0.9002

-0.0498 (-5.24%)

Last Updated: 11:37:13

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Quince Therapeutics Charts.

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Quince Therapeutics Charts.

Quince Therapeutics Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 13 May 2024 (5 hours ago) • Edgar (US Regulatory)

Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Monday 13 May 2024 (6 hours ago) • Business Wire

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Monday 6 May 2024 (7 days ago) • Business Wire

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Monday 1 April 2024 (1 month ago) • Business Wire

Quince Therapeutics Launches Scientific Advisory Board
Thursday 22 February 2024 (3 months ago) • Business Wire

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors
Thursday 15 February 2024 (3 months ago) • Business Wire

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
Wednesday 7 February 2024 (3 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Friday 5 January 2024 (4 months ago) • Edgar (US Regulatory)

Quince Therapeutics to Participate at Investor Events in January 2024
Thursday 4 January 2024 (4 months ago) • Business Wire

Form 8-K - Current report
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)

More Quince Therapeutics Inc News Articles

AMC Entertainment

GNCC Capital (CE)

Intergrated Cannabis Sol... (PK)

Net Savings Link (PK)

Asia Broadband (PK)

Decentral Life (PK)

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

Innerscope Hearing Techn... (PK)

BlackStar Enterprise (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions